Pharmafile Logo
Pharmafocus logo
Advanced Search

drugs

Showing 15 posts of 771 posts found.

Rising levels of opioid prescriptions puts NHS under pressure

March 16, 2018
Medical Communications NHS, biotech, drugs, opioid, pharma, pharmaceutical

It has been found that the number of prescriptions being written for opioid painkillers has risen from 10 million to …

News

Allergan navigating choppy waters, as shares rise and fall

March 16, 2018
Medical Communications Allergan, Brent Saunders, biotech, drugs, pharma, pharmaceutical

By most measures Allergan has not had the most successful of years and one measure, in particular, is usually indicative …

News
ears-2545756_960_720

Hearing drug failure puts biotech on brink

March 16, 2018
Medical Communications, Research and Development Auris, biotech, drugs, pharma, pharmaceutical

Biotechs with few products in the portfolio are always at a risk should results come back flat, it often leads …

News
fda_sign_web

Solid Biosciences rocked by clinical hold, shareholders flee

March 15, 2018
Research and Development Solid Biosciences, biotech, drugs, pharma, pharmaceutical

Solid Biosciences raised more than a few eyebrows when it only revealed a partial hold from the FDA stalling its …

News
obese-3011213_960_720

Fat-fighting pharma business files for bankruptcy

March 15, 2018
Sales and Marketing Contrave, biotech, drugs, orexigen, pharma, pharmaceutical

Orexigen Therapeutics, a biotech that was one of a wave of companies bringing through weight-loss pills, has announced that it …

News

Andrew Witty takes on a new CEO position

March 15, 2018
Medical Communications Andrew Witty, GSK, Optum, UnitedHealth, biotech, drugs, pharma, pharmaceutical

Andrew Witty, who made his name working his way up the ranks at GSK to become its CEO, has revealed …

News
veeva_event

Top 5 Reasons Why You Should Attend Veeva R&D Summit, Europe

March 15, 2018
Medical Communications biotech, drugs, pharma, pharmaceutical, veeva

Veeva R&D Summit, Europe is an annual gathering of pharma, biotech and medical devices professionals in clinical, regulatory, quality, and …

News
saroukos

Takeda’s CFO departs forcing company to act

March 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical

Takeda has announced that its Chief Financial Officer, James Kehoe, has decided to move on from the company to take …

Appointment
philip_hammond

Hammond suggests NHS may receive cash boost

March 14, 2018
Medical Communications, Research and Development Autumn Budget, NHS, UK, biotech, drugs, pharma, pharmaceutical

The pressures on the NHS over the winter months exposed serious cracks in the service, with issues regarding underfunding, struggles …

News
pills-384846_960_720

World’s first synthetic, non-biologic vaccine developed

March 14, 2018
Research and Development Vaccine, biotech, drugs, influenza, pharma, pharmaceutical

One of the major challenges in delivering vaccinations to all parts of the globe is the need to keep the …

News
abbvieuse_054_low

AbbVie secures further strong results for potential blockbuster

March 13, 2018
Research and Development AbbVie, biotech, drugs, elagolix, pharma, pharmaceutical

AbbVie’s elagolix has been slated as a blockbuster-in-the-making by analysts predicting big things for the potential treatment for uterine fibroids …

News
fda_building_web

Adaxis-AZ immunotherapy combo hit by clinical hold after death

March 13, 2018
Manufacturing and Production, Research and Development Adaxis, AstraZeneca, Imfinzi, biotech, drugs, immunotherapy, pharma, pharmaceutical

Adaxis and AstraZeneca announced that they had agreed a combination program for axalimogene filolisbac and Imfinzi, respectively, back in 2014 …

News
novartis_side_building

Novartis reshuffle begins under new CEO

March 13, 2018
Manufacturing and Production, Medical Communications Novartis, biotech, digital, drugs, pharma, pharmaceutical

It’s a common strategy that newly appointed CEOs will try to change the direction of the company via rejigging leadership …

News
biology-think-networking-physiology-brain-anatomy-2676370

Pfizer begins sell-off, shedding CNS drug to Biogen for $590m

March 13, 2018
Manufacturing and Production, Sales and Marketing Biogen, CNS, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer’s decision to back out of the neuroscience space was a strategic move that send shudders through the entire industry, …

News
diabetes-2424105_960_720

Study identifies five kinds of diabetes, potentially changing treatment

March 2, 2018
Medical Communications, Research and Development biotech, diabetes, drugs, pharma, pharmaceutical

A decade-long study has unearthed findings that could entirely change how people living with diabetes are treated, after the classic …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025